Literature DB >> 22491871

Habitual intake of dietary flavonoids and risk of Parkinson disease.

X Gao1, A Cassidy, M A Schwarzschild, E B Rimm, A Ascherio.   

Abstract

OBJECTIVE: To prospectively examine whether higher intakes of total flavonoids and their subclasses (flavanones, anthocyanins, flavan-3-ols, flavonols, flavones, and polymers) were associated with a lower risk of developing Parkinson disease (PD).
METHODS: In the current analysis, we included 49,281 men in the Health Professional Follow-up Study and 80,336 women from the Nurses' Health Study. Five major sources of flavonoid-rich foods (tea, berry fruits, apples, red wine, and orange/orange juice) were also examined. Flavonoid intake was assessed using an updated food composition database and a validated food frequency questionnaire.
RESULTS: We identified 805 participants (438 men and 367 women) who developed PD during 20-22 years of follow-up. In men, after adjusting for multiple confounders, participants in the highest quintile of total flavonoids had a 40%lower PD risk than those in the lowest quintile (hazard ratio [HR] = 0.60; 95% confidence interval 0.43, 0.83; p trend = 0.001). No significant relationship was observed in women (p trend = 0.62) or in pooled analyses (p trend = 0.23). In the pooled analyses for the subclasses, intakes of anthocyanins and a rich dietary source, berries, were significantly associated with a lower PD risk (HR comparing 2 extreme intake quintiles were 0.76 for anthocyanins and 0.77 for berries, respectively; p trend < 0.02 for both).
CONCLUSIONS: Our findings suggest that intake of some flavonoids may reduce PD risk, particularly in men, but a protective effect of other constituents of plant foods cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22491871      PMCID: PMC3320056          DOI: 10.1212/WNL.0b013e31824f7fc4

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC.

Authors:  John W Erdman; Douglas Balentine; Lenore Arab; Gary Beecher; Johanna T Dwyer; John Folts; James Harnly; Peter Hollman; Carl L Keen; G Mazza; Mark Messina; Augustin Scalbert; Joseph Vita; Gary Williamson; Jerrilynn Burrowes
Journal:  J Nutr       Date:  2007-03       Impact factor: 4.798

2.  Prospective study of dietary pattern and risk of Parkinson disease.

Authors:  Xiang Gao; Honglei Chen; Teresa T Fung; Giancarlo Logroscino; Michael A Schwarzschild; Frank B Hu; Alberto Ascherio
Journal:  Am J Clin Nutr       Date:  2007-11       Impact factor: 7.045

Review 3.  Flavonoids: modulators of brain function?

Authors:  Jeremy P E Spencer
Journal:  Br J Nutr       Date:  2008-05       Impact factor: 3.718

4.  Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's disease.

Authors:  Krishna P Datla; Virginia Zbarsky; Deepal Rai; Shabnam Parkar; Naomi Osakabe; Okezie I Aruoma; David T Dexter
Journal:  J Am Coll Nutr       Date:  2007-08       Impact factor: 3.169

5.  Plasma urate and risk of Parkinson's disease.

Authors:  M G Weisskopf; E O'Reilly; H Chen; M A Schwarzschild; A Ascherio
Journal:  Am J Epidemiol       Date:  2007-06-20       Impact factor: 4.897

Review 6.  B vitamins and berries and age-related neurodegenerative disorders.

Authors:  Ethan Balk; Mei Chung; Gowri Raman; Athina Tatsioni; Priscilla Chew; Stanley Ip; Deirdre DeVine; Joseph Lau
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2006-04

7.  Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.

Authors:  Tiina M Kääriäinen; Marjo Piltonen; Bernardino Ossola; Heli Kekki; Sárka Lehtonen; Terhi Nenonen; Anne Lecklin; Atso Raasmaja; Pekka T Männistö
Journal:  Brain Res       Date:  2008-02-13       Impact factor: 3.252

8.  Diet, urate, and Parkinson's disease risk in men.

Authors:  Xiang Gao; Honglei Chen; Hyon K Choi; Gary Curhan; Michael A Schwarzschild; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2008-03-07       Impact factor: 4.897

9.  (-)Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons.

Authors:  Hagen Schroeter; Parmvir Bahia; Jeremy P E Spencer; Olivia Sheppard; Marcus Rattray; Enrique Cadenas; Catherine Rice-Evans; Robert J Williams
Journal:  J Neurochem       Date:  2007-02-07       Impact factor: 5.372

Review 10.  Neuroinflammation and its modulation by flavonoids.

Authors:  K Vafeiadou; D Vauzour; J P E Spencer
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2007-09       Impact factor: 2.895

View more
  72 in total

1.  Perspective: Neuroregenerative Nutrition.

Authors:  Dennis A Steindler; Brent A Reynolds
Journal:  Adv Nutr       Date:  2017-07-14       Impact factor: 8.701

2.  Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s disease.

Authors:  Katherine E Strathearn; Gad G Yousef; Mary H Grace; Susan L Roy; Mitali A Tambe; Mario G Ferruzzi; Qing-Li Wu; James E Simon; Mary Ann Lila; Jean-Christophe Rochet
Journal:  Brain Res       Date:  2014-02-03       Impact factor: 3.252

3.  Association between apple consumption and physician visits: appealing the conventional wisdom that an apple a day keeps the doctor away.

Authors:  Matthew A Davis; Julie P W Bynum; Brenda E Sirovich
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

4.  Lumbee traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms.

Authors:  Aurélie de Rus Jacquet; Michael Timmers; Sin Ying Ma; Andrew Thieme; George P McCabe; Jay Hansford C Vest; Mary Ann Lila; Jean-Christophe Rochet
Journal:  J Ethnopharmacol       Date:  2017-02-15       Impact factor: 4.360

5.  Dietary nicotine intake and risk of Parkinson disease: a prospective study.

Authors:  Chaoran Ma; Samantha Molsberry; Yanping Li; Michael Schwarzschild; Alberto Ascherio; Xiang Gao
Journal:  Am J Clin Nutr       Date:  2020-10-01       Impact factor: 7.045

6.  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is selectively toxic to primary dopaminergic neurons in vitro.

Authors:  Amy M Griggs; Zeynep S Agim; Vartika R Mishra; Mitali A Tambe; Alison E Director-Myska; Kenneth W Turteltaub; George P McCabe; Jean-Christophe Rochet; Jason R Cannon
Journal:  Toxicol Sci       Date:  2014-04-09       Impact factor: 4.849

7.  Intake of antioxidant vitamins and risk of Parkinson's disease.

Authors:  Katherine C Hughes; Xiang Gao; Iris Y Kim; Eric B Rimm; Molin Wang; Marc G Weisskopf; Michael A Schwarzschild; Alberto Ascherio
Journal:  Mov Disord       Date:  2016-10-27       Impact factor: 10.338

8.  Dietary flavonoid intake at midlife and healthy aging in women.

Authors:  Cécilia Samieri; Qi Sun; Mary K Townsend; Eric B Rimm; Francine Grodstein
Journal:  Am J Clin Nutr       Date:  2014-10-29       Impact factor: 7.045

9.  AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific neuroprotection in a Parkinson's disease rat model.

Authors:  Krista McFarland; Diana L Price; Christopher N Davis; Jian-Nong Ma; Douglas W Bonhaus; Ethan S Burstein; Roger Olsson
Journal:  ACS Chem Neurosci       Date:  2013-08-06       Impact factor: 4.418

10.  Restless legs syndrome: an early clinical feature of Parkinson disease in men.

Authors:  Janice C Wong; Yanping Li; Michael A Schwarzschild; Alberto Ascherio; Xiang Gao
Journal:  Sleep       Date:  2014-02-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.